Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone formulations for chronic sinusitis after sinus surgery
ACTRN12608000140358Phase 2Recruiting
- Sponsor
- Naryx Pharmaceuticals
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fluticasone propionate and beclomethasone dipropionate in rhinosinusitis (3 arms), sponsored by Naryx Pharmaceuticals. Primary endpoint: Change from baseline in average Subject-Rated Total Sinus Symptom Score during the fourth week of therapy for each method of administration. Started Jul 2007; status: recruiting.
02
Drugs
fluticasone propionatebeclomethasone dipropionate
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on ACTRN12608000140358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000140358.